New Insights into the Genetic Association of Lipids and Lipid-Modifying Target Genes with Pancreatitis

Linbo Yao; Xinmin Yang; Robert Sutton; Qing Xia; Wei Huang

doi:10.1002/mco2.70554

MedComm ›› 2025, Vol. 6 ›› Issue (12) :e70554 DOI: 10.1002/mco2.70554

LETTER

New Insights into the Genetic Association of Lipids and Lipid-Modifying Target Genes with Pancreatitis

Author information +

History +

PDF

Cite this article

Download citation ▾

Linbo Yao, Xinmin Yang, Robert Sutton, Qing Xia, Wei Huang. New Insights into the Genetic Association of Lipids and Lipid-Modifying Target Genes with Pancreatitis. MedComm, 2025, 6(12): e70554 DOI:10.1002/mco2.70554

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	M. J. Murphy, X. Sheng, T. M. MacDonald, et al., “Hypertriglyceridemia and Acute Pancreatitis,” JAMA Internal Medicine 173 (2013): 162–164.

[2]	M. Davidson, M. Stevenson, A. Hsieh, et al., “The Burden of Familial Chylomicronemia Syndrome: Results From the Global in-FOCUS Study,” Journal of Clinical Lipidology 12 (2018): 898–907. e2.

[3]	V. J. Alexander, E. Karwatowska-Prokopczuk, T. A. Prohaska, et al., “Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia,” New England Journal of Medicine 390 (2024): 476–477.

[4]	G. F. Watts, R. S. Rosenson, R. A. Hegele, et al., “Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk,” New England Journal of Medicine 392 (2025): 127–137.

[5]	E. S. G. Stroes, V. J. Alexander, E. Karwatowska-Prokopczuk, et al., “Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome,” New England Journal of Medicine 390 (2024): 1781–1792.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.